Novo Nordisk A/S (NYSE:NVO)

47.16
Delayed Data
As of 4:02pm ET
 +0.28 / +0.60%
Today’s Change
37.27
Today|||52-Week Range
58.37
-12.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash2.3B2.5B2.7B3.0B
 
 
 
 
 
Short Term Investment Cash560.6M321.6M387.1M-199.6M
 
 
 
 
 
Cash & Short Term Investments2.6B3.0B3.0B3.4B
 
 
 
 
 
 
ReceivablesReceivables2.8B3.0B3.4B3.8B
 
 
 
 
 
 
InventoriesInventories1.8B1.9B2.0B2.5B
 
 
 
 
 
 
Current AssetsPrepaid Expenses198.6M127.9M----
 
 
 
Other Current Assets40.8M0.000.000.00
 
 
Current Assets7.5B8.0B8.5B9.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.7B7.4B8.2B10.4B
 
 
 
 
 
Depreciation-4.0B-3.7B-3.9B-4.7B
 
 
 
 
 
Intangible Assets223.9M314.1M385.0M536.3M
 
 
 
 
 
Other Assets223.9M314.1M385.0M536.3M
 
 
 
 
 
Total Assets12.5B13.4B13.8B16.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable804.4M717.2M852.7M904.8M
 
 
 
 
 
Short Term Debt117.0M156.2M32.5M273.2M
 
 
 
 
 
Accrued Expenses746.9M850.1M986.3M48.4M
 
 
 
 
 
Other Current Liabilities3.3B3.9B4.6B4.8B
 
 
 
 
 
Other Liabilities5.5B5.9B6.7B7.6B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-876.2M-989.8M-378.7M-176.6M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
 
 
Total Liabilities6.0B6.5B7.4B8.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.5B6.8B6.4B8.0B
 
 
 
 
 
Total Shareholder Equity6.5B6.8B6.4B8.0B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.0B2.0B1.9B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.